期刊
CLINICA CHIMICA ACTA
卷 488, 期 -, 页码 40-49出版社
ELSEVIER
DOI: 10.1016/j.cca.2018.10.036
关键词
Colorimetric assay; Gold nanoparticle; PCA3; Prostate cancer; Urine
资金
- National Research Council of Thailand
- Health Systems Research Institute [HSRI 60-026]
- Mahidol-Norway Capacity Building Initiative
Background: PCA3, a non-coding RNA, has been approved as a potential urinary biomarker for prostate cancer However, PCA3 urine tests have some limitations. Therefore, we developed a colorimetric method for PCA. detection in urine. Methods: The assay was based on interactions between unmodified gold nanopartides (AuNPs) and thiolated PCR products. Thiolated PCR products were amplified by RT-PCR using a thiol-labeled primer at the 5' end Thiolated products of PCA3 bound to the surface of AuNPs and led to the prevention of salt-induced aggregation (red color). In the absence of the PCR products, AuNPs changed their color from red to blue due to the salt induced aggregation. These changes were detected by the naked eye and spectrophotometer. Results: Our assay was specific for PCA3 in prostate cancer cell lines with a visual detection limit of 31.25 ng/reaction. The absorption ratio 520/640 nm was linear against PCR product concentration (R-2 = 0.9798) in the reaction. This method is promising for discrimination of prostate cancer patients from both healthy controls and benign prostatic hyperplasia patients according to their urinary PCA3 expression levels. Conclusions: This study established a simple, rapid, sensitive and specific assay for PCA3 detection which may be applicable for prostate cancer diagnosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据